This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.93% per year. These returns cover a period from January 1, 1988 through March 2, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
zacks-consensus-estimate: Archive
electroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
electroCore (ECOR) delivered earnings and revenue surprises of +1.45% and -0.18%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
ECORNegative Net Change IGCPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
Nyxoah (NYXH) delivered earnings and revenue surprises of -4.62% and -2.46%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
NYXHNegative Net Change PHRNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
FiscalNote Holdings, Inc. (NOTE) Reports Q4 Loss, Lags Revenue Estimates
by Zacks Equity Research
FiscalNote Holdings, Inc. (NOTE) delivered earnings and revenue surprises of +1.01% and -0.84%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
NOTENegative Net Change BITFNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Planet Labs PBC (PL) Reports Break-Even Earnings for Q4
by Zacks Equity Research
Planet Labs PBC (PL) delivered earnings and revenue surprises of +100.00% and +11.03%, respectively, for the quarter ended January 2026. Do the numbers hold clues to what lies ahead for the stock?
PLPositive Net Change INTZPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Eton Pharmaceuticals, Inc. (ETON) Q4 Earnings Lag Estimates
by Zacks Equity Research
Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -58.33% and +4.22%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
ETONPositive Net Change BRTXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
FedEx (FDX) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
FedEx (FDX) delivered earnings and revenue surprises of +26.81% and +1.75%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?
FDXPositive Net Change CSXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Assembly Biosciences (ASMB) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Assembly Biosciences (ASMB) delivered earnings and revenue surprises of +586.28% and +300.65%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
ASMBPositive Net Change TELANegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Intellicheck Mobilisa, Inc. (IDN) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Intellicheck Mobilisa (IDN) delivered earnings and revenue surprises of +243.35% and +6.16%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
IDNNegative Net Change LAKENegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Scholastic (SCHL) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Scholastic (SCHL) delivered earnings and revenue surprises of +58.90% and -0.59%, respectively, for the quarter ended February 2026. Do the numbers hold clues to what lies ahead for the stock?
SCHLPositive Net Change PEPPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Misses Revenue Estimates
by Zacks Equity Research
SolGel Technologies (SLGL) delivered earnings and revenue surprises of -374.36% and -89.29%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
SLGLPositive Net Change NRIXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank